Insights on the Asia-Pacific Defibrillators Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025

The Asia-Pacific market is considered to be one of the emerging market due to huge population of CVD, CHD, stroke and other heart diseases and is growing at a modest rate due to various factors such as the rising healthcare spending, improving infrastructure and economy, and rising standards of living. Improving healthcare system, prevalence of huge CVD, stroke, and heart patients and investment from private players are expected to drive the market in upcoming years. The APAC drugs market is predicted to contribute highest in the growth of cardiology market followed by device market due to huge adoption of cardiology drugs, high cost of drugs, and favourable government policies. APAC region includes China, India, Japan, Korea, Taiwan and other regions, which contribute significantly to the growth of cardiology market due to rising heart patients, government policies and adoption of robotic surgeries.

To Request a Sample of our Report on Asia-Pacific Defibrillators Market: https://www.omrglobal.com/request-sample/asia-pacific-defibrillators-market

The region is expected to grow significantly in the healthcare domain and particularly, there is huge advancement in the defibrillator market. The adoption of innovative devices and technological advancement created huge scope in the market. India, China, and Japan are medical tourism places for various countries due to cheaper surgery rates and treatment costs. Patients travel huge distances to get quality treatment at economical prices. The demand for implanted surgeries and devices is rising in the region due to medical tourism and rising heart patients across the region.

Geriatric population is also one of the major concerns for the Japanese government and other healthcare institution. For instance, in Japan, out of total 126 million population, about 27% population of the country was above 65 years in 2017. It is forecast that the population will reduce to 123 million in 2023 and geriatric population is forecast to be higher as compared to 2017. The incidence of heart stroke occurrence in geriatric population is relatively high as compared to young population. As per the Institute for Health Metrics and Evaluation, in 2017, around 0.2 million incidences of ischemic heart disease occurred in Japan. The prevalence of Ischemic heart disease in 2013 was 3.5 million peoples that have increased to 3.7 million in 2017, that contributes to the market growth.

(Get 15% Discount on Buying this Report)

A full Report of Asia-Pacific Defibrillators Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-defibrillators-market

Asia-Pacific Defibrillators Market Segmentation

By Type

· Implantable Cardioverter Defibrillators

· External Cardioverter Defibrillators

By End-Users

· Hospitals

· Ambulatory Services and Others

Regional Analysis

· China

· India

· Japan

Rest of Asia-Pacific

Company Profiles

· Abbott Laboratories,

· Cintas Corp.

· Defibtech LLC

· General Electric Co.

· Koninklijke Philips N.V.

· LivaNova PLC

· Medtronic PLC

· Mindray Medical International Co. Ltd.

· Nihon Kohden Corp.

· Stryker Corp.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.